MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, CLYM has $152,372K in assets. $4,287K in debts. $8,356K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
2785.65%
Quick Ratio
2785.65%
Cash Ratio
205.26%
Debt to Asset Ratio
2.81%
Unit: Thousand (K) dollars
Assets Breakdown
    • Short-term marketable securities
    • Long-term marketable securities
    • Cash and cash equivalents
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accrued external research and de...
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
8,356 35,685 25,803 22,682
Short-term marketable securities
101,208 65,395 61,098 62,021
Prepaid expenses and other current assets
3,840 4,769 4,063 2,681
Total current assets
113,404 105,849 90,964 87,384
Long-term marketable securities
36,741 59,572 88,930 102,702
Operating lease right-of-use assets
447 505 562 618
Property and equipment, net
250 288 318 314
Other long-term assets
1,530 1,530 1,530 1,368
Total assets
152,372 167,744 182,304 192,386
Accounts payable
860 2,269 477 946
Accrued external research and development expenses
1,318 ---
Accrued payroll and related expenses
984 ---
Accrued professional fees
533 ---
Other accrued expenses and current liabilities
113 ---
Accrued expenses and other current liabilities
2,948 4,459 4,244 5,037
Operating lease liabilities
263 256 228 222
Total current liabilities
4,071 6,984 4,949 6,205
Operating lease liabilities, net of current portion
216 285 352 417
Total liabilities
4,287 7,269 5,301 6,622
Common stock, 0.0001 par value 250,000,000 shares authorized 47,768,543 and 47,766,338 shares issued and outstanding at march 31, 2026 and december 31, 2025, respectively
5 5 7 7
Additional paid-in capital
451,372 449,762 448,738 444,762
Accumulated other comprehensive loss
157 435 469 318
Accumulated deficit
-303,449 -289,727 -272,211 -259,323
Total stockholders' equity
148,085 160,475 177,003 185,764
Total liabilities and stockholders' equity
152,372 167,744 182,304 192,386
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Short-term marketablesecurities$101,208K Cash and cashequivalents$8,356K Prepaid expenses andother current assets$3,840K Total current assets$113,404K Long-term marketablesecurities$36,741K Other long-termassets$1,530K Operating leaseright-of-use assets$447K Property and equipment,net$250K Total assets$152,372K Total liabilities andstockholders' equity$152,372K Total stockholders'equity$148,085K Total liabilities$4,287K Accumulated deficit-$303,449K Additional paid-in capital$451,372K Total currentliabilities$4,071K Operating leaseliabilities, net of current...$216K Accumulated othercomprehensive loss$157K Common stock, 0.0001par value...$5K Accrued expenses andother current...$2,948K Accounts payable$860K Operating leaseliabilities$263K Accrued externalresearch and development...$1,318K Accrued payroll andrelated expenses$984K Accrued professionalfees$533K Other accruedexpenses and current...$113K

Climb Bio, Inc. (CLYM)

Climb Bio, Inc. (CLYM)